SUBSCRIBE
SUBSCRIBE
News   Deals

Sinopharm IPO to Raise up to $1.13 Billion

September 4, 2009 | 
1 min read

Bookmark and Share

Reuters -- China’s largest pharmaceutical products distributor, Sinopharm Group Co Ltd, is set to raise up to HK$8.73 billion ($1.13 billion) in an initial public offering of shares in Hong Kong, according to a term sheet seen by Reuters on Friday.

IPO Asia
MORE ON THIS TOPIC
Pictured: AstraZeneca building in Gothenburg/iStoc
China
AstraZeneca Names New International Operations Lead Amid Probe on China Exec
December 5, 2024
 · 
3 min read
 · 
Tristan Manalac
Handshake gesture contemporary collage art. Celebrating success, congratulating for financial and business partnership, job contract deal, mutual friendship and respect. Abstract illustration isolated.
Alzheimer’s disease
GSK Strikes Third Agreement This Week, Leans Further Into Neuro
December 5, 2024
 · 
2 min read
 · 
Tristan Manalac
GSK's headquarters office building in Poznan, Poland
ADCs
GSK Turns Back to China in Another Potential $1B+ ADC Deal
December 4, 2024
 · 
1 min read
 · 
Kate Goodwin
Crowdfunding concept with money icon and human hands in retro 80s collage mixed media vector illustration. Idea for financing business project, funding, philanthropy, cooperation, bank credit and startup development.
Series A
Obesity-Focused Antag Debuts With $84M and Backing From Novo Holdings
December 4, 2024
 · 
2 min read
 · 
Heather McKenzie